← Back
Data updated: Mar 10, 2026
HETERO LABS LIMITED
Oncology
HETERO LABS LIMITED is a pharmaceutical company focused on Oncology. Key products include CYCLOPHOSPHAMIDE.
-
Since
5
Drugs
-
Trials
9
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
CYCLOPHOSPHAMIDE 2025-07-11
Labeling
CYCLOPHOSPHAMIDE 2025-03-11
Labeling
CYCLOPHOSPHAMIDE 2024-12-30
Labeling
CYCLOPHOSPHAMIDE 2024-12-26
CYCLOPHOSPHAMIDE 2024-12-19
CYCLOPHOSPHAMIDE 2024-12-03
CYCLOPHOSPHAMIDE 2024-10-29
AZILSARTAN MEDOXOMIL 2024-07-18
Labeling
CYCLOPHOSPHAMIDE 2024-03-29
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 100%
1 drugs
Pipeline Strength Pro
Loading...